Researchers have published a peer-reviewed study of two Sinopharm COVID-19 vaccines - with the results showing strong efficacy in protecting against COVID-19.
The findings were published overnight in the Journal of the American Medical Association after more than 40,000 volunteers were given either a placebo, or one of two vaccines.
The two inactivated vaccines showed 72.8 per cent and 78.1 per cent efficacy.
The report concluded: "Treatment of adults with either of 2 inactivated SARS-CoV-2 vaccines significantly reduced the risk of symptomatic COVID-19, and serious adverse events were rare."
None of the volunteers given an active vaccine developed severe disease, compared with two of those given placebo.
The study was completed by researchers in Wuhan, China, and the UAE, including Dr Nawal Al Kaabi of the Abu Dhabi Health Services Company, (SEHA).
Debris from interception hits Dubai building, no injuries
UAE orders arrest of 10 for publishing misleading online content
Abu Dhabi Police arrest 45 for filming incident sites, sharing rumours
UAE Cyber Security Council warns against 'Wiper' malware
Dubai Police crack down on noisy cars, illegal modifications
UAE President, Ethiopian PM discuss boosting economic, development ties
UAE air forces respond to more missile threats on Friday
UAE air defences intercept 7 ballistic missiles and 27 drones on Friday
